Japanese government

The firm's ROS1 gene fusion kit was approved as a companion diagnostic for Pfizer's Xalkori.

The Japan Times says regulations are needed to oversee human genome-editing research.

Got to Get Ahead

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Japan is creating its first biosafety level-4 lab in response to concerns about the Ebola outbreak, Nature News reports.

The center, based in Yokohama, Japan, will likely purchase at least one single-molecule sequencer in order to avoid PCR-induced bias in Cap Analysis of Gene Expression, a method its researchers developed.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.